Gizmodo

New research suggests that Eli Lilly’s tirzepatide can boost existing efforts to lose weight. The company’s latest clinical trial found that people who dropped at least 5% of their weight before taking the drug went on to lose substantially more weight than those who took a placebo. Those in the treatment group…

Read more...

Gizmodo

The arms race over the next generation of obesity drugs is continuing to heat up.

Gizmodo

The makers of two popular but off-label weight loss drugs are now being sued over complications allegedly linked to their use. This week, a Louisiana woman filed a complaint against the companies Novo Nordisk and Eli Lilly, arguing that they have misled patients about the risk of severe gastrointestinal side effects…

Tech Insider
ozempic pen
Semaglutide is a weekly injection that mimics a hunger-regulating hormone in the body.